Key result
AF-related mortality in hypertensive US adults rose nearly ~10-fold between 1999 and 2023.
Why the study?
AF is a leading arrhythmia contributing to cardiovascular mortality in individuals with HTN, yet long-term national trends and sociodemographic disparities in AF-related mortality remained underexplored.
Observational (n=1,108,265)
Yes
Atrial fibrillation-related mortality among hypertensive US adults aged 25 and older increased nearly tenfold between 1999 and 2023, with pronounced disparities affecting men, non-Hispanic Whites, and rural populations.
Answers are grounded in this paper and cite their sources.
Rising AF-related mortality in hypertensive adults warrants clinical vigilance; leaves open drivers of the surge and optimal interventions.
Background Atrial fibrillation (AF) is a leading arrhythmia contributing to cardiovascular mortality, particularly among individuals with Hypertension (HTN), yet long‐term trends and disparities remain underexplored. We analyzed national patterns and sociodemographic differences in AF‐related mortality among US adults aged 25 years or older from 1999 to 2023. Methods We used CDC WONDER mortality data (1999–2023) to analyze AF‐related deaths among US adults aged ≥ 25 with HTN. Age‐adjusted mortality rates (AAMR) per 100 000 and average annual percent changes (AAPC) were calculated using Joinpoint regression to assess overall and subgroup‐specific trends. Results AF accounted for 1 108 265 deaths among adults with HTN, with AAMRs increasing from 3.8 in 1999 to 35.9 in 2023 (AAPC: 6.03%). The sharpest rise occurred from 2018 to 2021, with an APC of 14.57%, coinciding with the COVID‐19 pandemic. Men had higher AAMRs than women (20.5 vs. 17.1). Racial disparities were evident, with non‐Hispanic Whites having the highest AAMR (20.1), followed by non‐Hispanic Blacks (15.1), Hispanics (11.3), and non‐Hispanic Others (10.7). Regional variation showed that the West had the highest AAMR (20.8), while Vermont recorded the highest state rate (28.7), and Nevada had the lowest (11.4). Rural areas exhibited higher mortality rates than urban areas (17.8 vs. 16.1), with rural AAMRs increasing at a faster rate (AAPC: 10.61%). Conclusion The rising burden of AF‐related mortality in hypertensive patients, especially among men, non‐Hispanic Whites, and rural populations, signals a critical public health concern. Immediate, equity‐focused interventions are needed to mitigate disparities and reduce AF‐related mortality across the United States.
No takes yet. Share an insight, caveat, or question.
Naveed et al. (2026) conducted an observational in Atrial fibrillation and hypertension (n=1,108,265). Atrial fibrillation in hypertension over time (2023 vs 1999) vs. Baseline year (1999) and sociodemographic subgroups was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 persons for atrial fibrillation in hypertensive adults (AAPC 6.03%, 95% CI 5.61-6.59, p=<0.001). Atrial fibrillation-related age-adjusted mortality in hypertensive US adults aged ≥25 rose from 3.8 per 100,000 in 1999 to 35.9 in 2023.
Synapse has enriched 10 related papers. Consider them for comparative context: